GENOMIC DIAGNOSTIC COMPANIES EYE IPOs. The opening IPO market is especially appealing for companies interested in sequencing diagnostics. We may be in the edge of a new wave of important tools that have adequate financing to do the job right.
http://lnkd.in/BS4ibC
linkedin post 2022-06-29 05:12:48
Nigel Fleming
September 21, 2022